G Zambruno Selected Research

G Zambruno Research Topics

Disease

8	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 01/2018 - 11/2000
5	Bullous Pemphigoid (Pemphigoid) 10/2021 - 01/2001
4	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 11/2019 - 09/2002
4	Skin Diseases (Skin Disease) 07/2006 - 11/2000
3	Pemphigus (Pemphigus Vulgaris) 09/2020 - 01/2006
3	Wounds and Injuries (Trauma) 01/2006 - 09/2000
2	Neoplasms (Cancer) 10/2021 - 12/2000
2	COVID-19 01/2021 - 11/2020
2	Infections 01/2021 - 03/2001
2	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 02/2017 - 04/2014
2	Atrophy 09/2015 - 01/2001
2	Ichthyosis (Xeroderma) 02/2013 - 10/2012
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2013 - 11/2004
2	Melanoma (Melanoma, Malignant) 05/2011 - 12/2000
2	Ulcer 01/2006 - 10/2002
2	Epidermolysis bullosa with pyloric atresia 10/2004 - 10/2003
1	Chilblains (Chilblain) 01/2021
1	Genetic Skin Diseases 11/2019
1	Fibrosis (Cirrhosis) 11/2019
1	Inflammation (Inflammations) 11/2019
1	Keloid 11/2019
1	Hypertrophic Cicatrix (Hypertrophic Scar) 11/2019
1	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 06/2018
1	Linear IgA Bullous Dermatosis 07/2017
1	Acne Vulgaris 06/2017
1	Alopecia Areata 02/2017
1	Skin Neoplasms (Skin Cancer) 09/2015
1	Poikiloderma of Kindler 09/2015
1	Netherton Syndrome 02/2013
1	Atopic Dermatitis (Atopic Eczema) 02/2013
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 10/2012
1	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 09/2011
1	Neoplasm Metastasis (Metastasis) 05/2011
1	Reinfection 01/2008
1	Hypersensitivity (Allergy) 06/2007
1	Thyroid Diseases (Thyroid Disease) 07/2006
1	Thyroiditis 07/2006
1	Dermatitis Herpetiformis (Disease, Duhring's) 01/2006
1	Acantholysis 01/2006
1	Chronic Urticaria 01/2006
1	Leg Ulcer 01/2006
1	Skin Ulcer 01/2006
1	Urticaria (Hives) 01/2006
1	Varicose Ulcer (Ulcer, Venous) 01/2006
1	Foreign Bodies (Foreign Body) 01/2005
1	Scabies (Sarcoptic Mange) 06/2004
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 09/2002

Drug/Important Bio-Agent (IBA)

5	AutoantibodiesIBA 02/2017 - 11/2004
5	Proteins (Proteins, Gene)FDA Link 09/2015 - 09/2000
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 09/2000
4	KalininIBA 10/2021 - 11/2000
4	Immunoglobulin A (IgA)IBA 01/2021 - 01/2006
4	Placenta Growth FactorIBA 05/2011 - 09/2000
4	AntigensIBA 07/2006 - 01/2001
3	Collagen Type VIIIBA 11/2019 - 09/2002
3	CytokinesIBA 01/2006 - 09/2000
3	Messenger RNA (mRNA)IBA 01/2006 - 09/2000
2	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 09/2021
2	AntibodiesIBA 01/2021 - 01/2006
2	CollagenIBA 11/2019 - 07/2006
2	Epidermal Growth Factor (EGF)IBA 01/2018 - 09/2000
2	Laminin (Merosin)IBA 01/2018 - 07/2006
2	EnzymesIBA 10/2012 - 11/2004
2	Nonsense Codon (Nonsense Mutation)IBA 01/2011 - 01/2001
2	Integrin beta4IBA 10/2004 - 10/2003
2	IntegrinsIBA 11/2001 - 03/2001
1	Rituximab (Mabthera)FDA Link 09/2020
1	transgelinIBA 11/2019
1	Contractile ProteinsIBA 11/2019
1	MicroRNAs (MicroRNA)IBA 11/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2017
1	Isotretinoin (Accutane)FDA LinkGeneric 06/2017
1	squaric acid dibutyl esterIBA 02/2017
1	Prostaglandins AIBA 07/2016
1	transglutaminase 1IBA 10/2012
1	Keratins (Keratin)IBA 09/2011
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 05/2011
1	potassium bromateIBA 06/2007
1	Fibronectins (Fibronectin)IBA 07/2006
1	AutoantigensIBA 01/2006
1	Immunoglobulin E (IgE)IBA 01/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2006
1	IgE Receptors (Fc epsilon RI)IBA 01/2006
1	Desmosomal CadherinsIBA 01/2006
1	DesmogleinsIBA 01/2006
1	Desmoglein 3IBA 01/2006
1	AcidsIBA 01/2005
1	Immunodominant EpitopesIBA 11/2004
1	Immunoglobulin G (IgG)IBA 11/2004
1	loricrinIBA 11/2004
1	ImmunosorbentsIBA 11/2004
1	Ivermectin (Mectizan)FDA Link 06/2004
1	Streptozocin (Streptozotocin)FDA Link 10/2002
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2002
1	Phenylalanine (L-Phenylalanine)FDA Link 11/2001
1	Complementary DNA (cDNA)IBA 11/2001

Therapy/Procedure

2	Therapeutics 06/2018 - 06/2004
1	Immunotherapy 02/2017
1	Aftercare (After-Treatment) 01/2006
1	Intradermal Injections 01/2006